Bayer Aktiengesellschaft (BAYN)

Basic

  • Market Cap

    €30.81B

  • EV

    €69.09B

  • Shares Out

    982.42M

  • Revenue

    €47.78B

  • Employees

    100,873

Margins

  • Gross

    60.13%

  • EBITDA

    20.69%

  • Operating

    4.11%

  • Pre-Tax

    -5.01%

  • Net

    -7.68%

  • FCF

    -1.06%

Returns (5Yr Avg)

  • ROA

    3.65%

  • ROE

    0.12%

  • ROCE

    7.68%

  • ROIC

    5.04%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €54.29

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    €48.63

  • Earnings (Dil)

    -€3.74

  • FCF

    -€0.52

  • Book Value

    €33.98

Growth (CAGR)

  • Rev 3Yr

    4.26%

  • Rev 5Yr

    6.43%

  • Rev 10Yr

    1.76%

  • Dil EPS 3Yr

    -38.76%

  • Dil EPS 5Yr

    -10.73%

  • Dil EPS 10Yr

    -0.02%

  • Rev Fwd 2Yr

    -2.09%

  • EBITDA Fwd 2Yr

    -7.97%

  • EPS Fwd 2Yr

    -11.5%

  • EPS LT Growth Est

    -3.44%

Dividends

  • Yield

  • Payout

    -64.3%

  • DPS

    €2.4

  • DPS Growth 3Yr

    -5.01%

  • DPS Growth 5Yr

    -3.04%

  • DPS Growth 10Yr

    2.36%

  • DPS Growth Fwd 2Yr

    -1.62%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Total Revenues

36,742.0

43,545.0

41,400.0

44,081.0

50,739.0

47,775.0

Total Revenues % Chg.

4.9%

18.5%

-4.9%

6.5%

15.1%

-4.2%

Cost of Goods Sold, Total

13,069.0

16,423.0

15,727.0

17,045.0

18,886.0

19,046.0

Gross Profit

23,673.0

27,122.0

25,673.0

27,036.0

31,853.0

28,729.0

Selling General & Admin Expenses, Total

13,238.0

14,801.0

13,886.0

14,531.0

16,036.0

14,881.0

R&D Expenses

4,701.0

5,282.0

4,884.0

5,326.0

6,168.0

5,511.0

Other Operating Expenses

1,477.0

59.0

-69.0

-296.0

528.0

6,373.0

Other Operating Expenses, Total

19,416.0

20,142.0

18,701.0

19,561.0

22,732.0

26,765.0

Operating Income

4,257.0

6,980.0

6,972.0

7,475.0

9,121.0

1,964.0

Interest Expense, Total

-1,401.0

-1,689.0

-1,500.0

-930.0

-1,058.0

-1,094.0

Interest And Investment Income

319.0

294.0

202.0

346.0

379.0

379.0

Net Interest Expenses

-1,082.0

-1,395.0

-1,298.0

-584.0

-679.0

-715.0

Income (Loss) On Equity Invest.

68.0

160.0

-96.0

49.0

-150.0

-169.0

Currency Exchange Gains (Loss)

-137.0

58.0

-216.0

-385.0

-219.0

-285.0

Other Non Operating Income (Expenses)

153.0

-3.0

102.0

-384.0

-844.0

-699.0

EBT, Excl. Unusual Items

3,259.0

5,800.0

5,464.0

6,171.0

7,229.0

96.0

Restructuring Charges

Merger & Related Restructuring Charges

-124.0

Impairment of Goodwill

-208.0

-2,238.0

-734.0

-734.0

Gain (Loss) On Sale Of Investments

-155.0

30.0

541.0

-3.0

-450.0

-382.0

Gain (Loss) On Sale Of Assets

-132.0

Asset Writedown

4,277.0

439.0

126.0

218.0

1,691.0

1,691.0

Insurance Settlements

Legal Settlements

-677.0

-546.0

-13,330.0

-3,689.0

-791.0

-791.0

Other Unusual Items

-4,562.0

-2,662.0

-7,813.0

-651.0

-2,275.0

-2,275.0

EBT, Incl. Unusual Items

1,886.0

2,853.0

-17,250.0

2,046.0

4,670.0

-2,395.0

Income Tax Expense

496.0

443.0

-1,689.0

1,024.0

504.0

1,280.0

Earnings From Continuing Operations

1,390.0

2,410.0

-15,561.0

1,022.0

4,166.0

-3,675.0

Earnings Of Discontinued Operations

321.0

1,700.0

5,074.0

Minority Interest

-16.0

-19.0

-8.0

-22.0

-16.0

8.0

Net Income

1,695.0

4,091.0

-10,495.0

1,000.0

4,150.0

-3,667.0

Net Income to Common Incl Extra Items

1,695.0

4,091.0

-10,495.0

1,000.0

4,150.0

-3,667.0

Net Income to Common Excl. Extra Items

1,374.0

2,391.0

-15,569.0

1,000.0

4,150.0

-3,667.0

Total Shares Outstanding

932.6

982.4

982.4

982.4

982.4

982.4

Weighted Avg. Shares Outstanding

940.8

981.7

982.4

982.4

982.4

982.4

Weighted Avg. Shares Outstanding Dil

940.8

981.7

982.4

982.4

982.4

982.4

EPS

1.8

4.2

-10.7

1.0

4.2

-3.7

EPS Diluted

1.8

4.2

-10.7

1.0

4.2

-3.7

EBITDA

7,145.0

10,810.0

10,030.0

10,877.0

12,705.0

9,886.0